Company Profile
We are a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. We have a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine...
Volume:
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Innovative Procedural Solutions
Strengthened Distributor Partnerships
Improved Clinical Outcomes and Economic Value
Well capitalized to Execute Strategy
Q3 2020 Financial and Operational Highlights
66%
% of U.S. Spinal Implants Revenue from Recently Launched Products
5
Product Launches
67.4%
Gross Margin
$129.7M
Total Potential Liquidity
55%
% of U.S. Revenue from Core Distributors